<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39334045</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6963</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>BMC health services research</Title><ISOAbbreviation>BMC Health Serv Res</ISOAbbreviation></Journal><ArticleTitle>COVID-19 inpatient care performance in the unified health system, São Paulo state, Brazil: an application of standardized mortality ratio for hospitals' comparisons : COVID-19 inpatient care performance in SUS, Brazil.</ArticleTitle><Pagination><StartPage>1125</StartPage><MedlinePgn>1125</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1125</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12913-024-11496-w</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the variation in COVID-19 inpatient care mortality among hospitals reimbursed by the Unified Health System (SUS) in the first two years of the pandemic in São Paulo state and make performance comparisons within periods and over time.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Observational study based on secondary data from the Hospital Information System. The study universe consisted of 289,005 adult hospitalizations whose primary diagnosis was COVID-19 in five periods from 2020 to 2022. A multilevel regression model was applied, and the death predictive variables were sex, age, Charlson Index, obesity, type of admission, Brazilian Deprivation Index (BrazDep), the month of admission, and hospital size. Then, the total observed deaths and total deaths predicted by the model's fixed effect component were aggregated by each hospital, estimating the Standardized Mortality Ratio (SMR) in each period. Funnel plots with limits of two standard deviations were employed to classify hospitals by performance (higher-than-expected, as expected, and lower-than-expected) and determine whether there was a change in category over the periods.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A positive association was observed between hospital mortality and size (number of beds). There was greater variation in the percentage of hospitals with as-expected performance (39.5 to 76.1%) and those with lower-than-expected performance (6.6 to 32.3%). The hospitals with higher-than-expected performance remained at around 30% of the total, except in the fifth period. In the first period, 64 hospitals (18.3%) had lower-than-expected performance, with standardized mortality ratios ranging from 1.2 to 4.4, while in the last period, only 23 (6.6%) hospitals were similarly classified, with ratios ranging from 1.3 to 2.8. A trend of homogenization and adjustment to expected performance was observed over time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Despite the study's limitations, the results suggest an improvement in the COVID-19 inpatient care performance of hospitals reimbursed by the SUS in São Paulo over the period studied, measured by the standardized mortality ratio for hospitalizations due to COVID-19. Moreover, the methodological approach adapted to the Brazilian context provides an applicable tool to follow-up hospital's performance in caring all or specific-cause hospitalizations, in regular or exceptional emergency situations.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Marla Presa Raulino</ForeName><Initials>MPR</Initials><Identifier Source="ORCID">0000-0001-5544-4715</Identifier><AffiliationInfo><Affiliation>Department of Health Administration and Planning, Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation, INOVA Fiocruz Post-doctoral Program, Rio de Janeiro, RJ, Brazil. marla_presa_raulino@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portela</LastName><ForeName>Margareth Crisóstomo</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0002-9858-9276</Identifier><AffiliationInfo><Affiliation>Department of Health Administration and Planning, Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Albuquerque</LastName><ForeName>Mariana Vercesi</ForeName><Initials>MV</Initials><Identifier Source="ORCID">0000-0002-0763-6357</Identifier><AffiliationInfo><Affiliation>Department of Health Administration and Planning, Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Mônica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9962-0618</Identifier><AffiliationInfo><Affiliation>Department of Health Administration and Planning, Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>VPPCB-007-FIO-18</GrantID><Agency>Inova Fiocruz Program</Agency><Country /></Grant><Grant><GrantID>VPPCB-007-FIO-18</GrantID><Agency>Inova Fiocruz Program</Agency><Country /></Grant><Grant><GrantID>VPPCB-007-FIO-18</GrantID><Agency>Inova Fiocruz Program</Agency><Country /></Grant><Grant><GrantID>VPPCB-007-FIO-18</GrantID><Agency>Inova Fiocruz Program</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Health Serv Res</MedlineTA><NlmUniqueID>101088677</NlmUniqueID><ISSNLinking>1472-6963</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009313" MajorTopicYN="N">National Health Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Healthcare quality</Keyword><Keyword MajorTopicYN="N">Hospital mortality</Keyword><Keyword MajorTopicYN="N">Outcome assessment (healthcare)</Keyword><Keyword MajorTopicYN="N">Risk adjustment</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334045</ArticleId><ArticleId IdType="pmc">PMC11428977</ArticleId><ArticleId IdType="doi">10.1186/s12913-024-11496-w</ArticleId><ArticleId IdType="pii">10.1186/s12913-024-11496-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Haldane V, De Foo C, Abdalla SM, et al. Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med. 2021;27(6):964–80.</Citation><ArticleIdList><ArticleId IdType="pubmed">34002090</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik MA. Fragility and challenges of health systems in pandemic: lessons from India’s second wave of coronavirus disease 2019 (COVID-19). Glob Health J Amst Neth. 2022;6(1):44–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767801</ArticleId><ArticleId IdType="pubmed">35070474</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha R, Atun R, Massuda A, et al. Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis. Lancet Glob Health. 2021;9(6):e782–92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041360</ArticleId><ArticleId IdType="pubmed">33857500</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ginneken E, Webb E, Maresso A, Cylus J. HSRM network. Lessons learned from the COVID-19 pandemic. Health Policy Amst Neth. 2022;126(5):348–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8993495</ArticleId><ArticleId IdType="pubmed">35568674</ArticleId></ArticleIdList></Reference><Reference><Citation>Portela MC, de Aguiar Pereira CC, Lima SML, de Andrade CLT, Martins M. Patterns of hospital utilization in the Unified Health System in six Brazilian capitals: comparison between the year before and the first six first months of the COVID-19 pandemic. BMC Health Serv Res. 2021;21(1):976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8445784</ArticleId><ArticleId IdType="pubmed">34535135</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Lond Engl. 2020;395(10229):1054–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Mostert C, Hentschker C, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8(9):853–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386882</ArticleId><ArticleId IdType="pubmed">32735842</ArticleId></ArticleIdList></Reference><Reference><Citation>Baqui P, Bica I, Marra V, Ercole A, van der Schaar M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. Lancet Glob Health. 2020;8(8):e1018–26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332269</ArticleId><ArticleId IdType="pubmed">32622400</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrade CLT, Pereira CC, de Martins A, Lima M, Portela SML. COVID-19 hospitalizations in Brazil’s Unified Health System (SUS). Nunes BP. ed PLOS ONE. 2020;15(12):e0243126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7728222</ArticleId><ArticleId IdType="pubmed">33301479</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray WK, Navaratnam AV, Day J, et al. Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: a national observational study for the getting it right first Time Programme. EClinicalMedicine. 2021;35:100859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072185</ArticleId><ArticleId IdType="pubmed">33937732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzani OT, Bastos LSL, Gelli JGM, et al. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021;9(4):407–18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834889</ArticleId><ArticleId IdType="pubmed">33460571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua MJ, Feinglass J. Variations in COVID-19 hospital mortality by Patient Race/Ethnicity and Hospital Type in Illinois. J Racial Ethn Health Disparities. 2023;10(2):911–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900642</ArticleId><ArticleId IdType="pubmed">35257313</ArticleId></ArticleIdList></Reference><Reference><Citation>Portela MC, Martins M, Lima SML, de Andrade CLT, de Aguiar Pereira CC. COVID-19 inpatient mortality in Brazil from 2020 to 2022: a cross-sectional overview study based on secondary data. Int J Equity Health. 2023;22(1):238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10655483</ArticleId><ArticleId IdType="pubmed">37978531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottle A, Faitna P, Aylin PP. Patient-level and hospital-level variation and related time trends in COVID-19 case fatality rates during the first pandemic wave in England: multilevel modelling analysis of routine data. BMJ Qual Saf. 2022;31(3):211–20.</Citation><ArticleIdList><ArticleId IdType="pubmed">34234008</ArticleId></ArticleIdList></Reference><Reference><Citation>Asch DA, Sheils NE, Islam MN, et al. Variation in US Hospital Mortality Rates for patients admitted with COVID-19 during the First 6 months of the pandemic. JAMA Intern Med. 2021;181(4):471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7756246</ArticleId><ArticleId IdType="pubmed">33351068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzani OT, Hitchings MDT, Dorion M, et al. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of COVID-19 in Brazil: test negative case-control study. BMJ. 2021;374:n2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8377801</ArticleId><ArticleId IdType="pubmed">34417194</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth GA, Emmons-Bell S, Alger HM, et al. Trends in patient characteristics and COVID-19 In-Hospital mortality in the United States during the COVID-19 pandemic. JAMA Netw Open. 2021;4(5):e218828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094014</ArticleId><ArticleId IdType="pubmed">33938933</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiaravalloti Neto F, Bermudi PMM, de Aguiar BS, Failla MA, Barrozo LV, Toporcov TN. COVID-19 hospital mortality using spatial hierarchical models: cohort design with 74,994 registers. Rev Saúde Pública. 2023;57:2s.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10185308</ArticleId><ArticleId IdType="pubmed">37255113</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigoni A, Malik AM, Tasca R, et al. Brazil’s health system functionality amidst of the COVID-19 pandemic: an analysis of resilience. Lancet Reg Health - Am. 2022;10:100222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8896985</ArticleId><ArticleId IdType="pubmed">35284904</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C. Deconstructing improvements and hospital variation in COVID-19 mortality rates during the early pandemic wave: the effects of wave evolution and advances in testing, treatment, and hospital care quality. BMJ Qual Saf. 2022;31(3):168–71.</Citation><ArticleIdList><ArticleId IdType="pubmed">34353959</ArticleId></ArticleIdList></Reference><Reference><Citation>de Freitas CM, Barcellos C, Villela DAM, Matta GC, Reis LG da, Portela C. MC. COVID-19: balanço de dois anos da pandemia aponta vacinação como prioridade. Fiocruz. 2022. https://portal.fiocruz.br/noticia/covid-19-balanco-de-dois-anos-da-pandemia-aponta-vacinacao-como-prioridade. Accessed 23 Oct 2023.</Citation></Reference><Reference><Citation>Aylin P, Bottle A, Majeed A. Use of administrative data or clinical databases as predictors of risk of death in hospital: comparison of models. BMJ. 2007;334(7602):1044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1871739</ArticleId><ArticleId IdType="pubmed">17452389</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosmer DW, Lemeshow S. Confidence interval estimates of an index of quality performance based on logistic regression models. Stat Med. 1995;14(19):2161–72.</Citation><ArticleIdList><ArticleId IdType="pubmed">8552894</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>CIDACS. Centro de Integração de Dados e Conhecimentos para Saúde. Índice Brasileiro de Privação Social (IBP). CIDACS/Fiocruz Bahia. 2021. https://cidacs.bahia.fiocruz.br/ibp/base-de-dados-do-ibp-municipal-esta-disponivel-para-download/. Accessed 10 Oct 2023.</Citation></Reference><Reference><Citation>Tom AB, Snijders RB. Multilevel analysis: an introduction to Basic and Advanced Multilevel modeling. 2nd ed. Sage Publications Ltd.; 2011.</Citation></Reference><Reference><Citation>Aquino EML. Medidas De Distanciamento social no controle da pandemia de COVID-19: Potenciais Impactos E desafios no Brasil. Ciênc Saúde Coletiva. 2020;25:2423–46.</Citation><ArticleIdList><ArticleId IdType="pubmed">32520287</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura EC, Cortez-Escalante J, Cavalcante FV, Barreto ICDHC, Sanchez MN, Santos LMP. COVID-19: evolução temporal e imunização nas três ondas epidemiológicas, Brasil, 2020–2022. Rev Saúde Pública. 2022;56:105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749655</ArticleId><ArticleId IdType="pubmed">36515307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottle A, Faitna P, Brett S, Aylin P. Factors associated with, and variations in, COVID-19 hospital death rates in England’s first two waves: observational study. BMJ Open. 2022;12(6):e060251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9247323</ArticleId><ArticleId IdType="pubmed">35772812</ArticleId></ArticleIdList></Reference><Reference><Citation>Muñoz-Corona C, Lara-Lona E, Chávez CAD, Vargas GF, Martínez DAD, Magos-Vázquez FJ. Analysis of Hospital lethality of COVID-19 in Mexico. Biomed Pharmacol J. 2021;14(4):2157–64.</Citation></Reference><Reference><Citation>Perondi B, Miethke-Morais A, Montal AC, Harima L, Segurado AC. Setting up hospital care provision to patients with COVID-19: lessons learnt at a 2400-bed academic tertiary center in São Paulo, Brazil. Braz J Infect Dis. 2021;24:570–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604059</ArticleId><ArticleId IdType="pubmed">33157034</ArticleId></ArticleIdList></Reference><Reference><Citation>Meira ALP, Godoi LPDS, Ibañez N, Viana ALD, Louvison MCP. Gestão regional no enfrentamento à Pandemia Da COVID-19: estudo de casos em São Paulo. Saúde Em Debate. 2023;47(138):418–30.</Citation></Reference><Reference><Citation>Barberia LG, de Moreira P, Kemp N. Evaluation of the effectiveness of surveillance policies to control the COVID-19 pandemic in São Paulo, Brazil. Glob Health Res Policy. 2022;7(1):27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9381395</ArticleId><ArticleId IdType="pubmed">35974420</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpanez LR, Malik AM. O efeito da municipalização no sistema hospitalar brasileiro: os hospitais de pequeno porte. Ciênc Saúde Coletiva. 2021;26:1289–98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33886758</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrasco. Dossiê Abrasco - Pandemia de COVID-19. 2022. https://abrasco.org.br/download/dossie-abrasco-pandemia-de-covid-19/. Accessed 12 Oct 2023.</Citation></Reference><Reference><Citation>Endo H, Lee K, Ohnuma T, Watanabe S, Fushimi K. Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: a retrospective cohort study. J Infect Chemother off J Jpn Soc Chemother. 2022;28(10):1393–401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239980</ArticleId><ArticleId IdType="pubmed">35779801</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegelhalter DJ. Funnel plots for comparing institutional performance. Stat Med. 2005;24(8):1185–202.</Citation><ArticleIdList><ArticleId IdType="pubmed">15568194</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegelhalter D, Sherlaw-Johnson C, Bardsley M, Blunt I, Wood C, Grigg O. Statistical methods for healthcare regulation: rating, screening and surveillance: statistical methods for Healthcare Regulation. J R Stat Soc Ser Stat Soc. 2012;175(1):1–47.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>